Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06510244 · ClinicalTrials.gov registry record

Pain Perception Measurement by EEG and NRS

A clinical trial of Pain and Electroencephalography, sponsored by Cleveland Dental Institute.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT06510244: Recruiting study of Pain and Electroencephalography, sponsored by Cleveland Dental Institute.

NCT06510244 is a study of Pain and Electroencephalography that is actively recruiting participants, run by Cleveland Dental Institute. The registered enrollment target is 100 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06510244, a study of Pain and Electroencephalography, is actively recruiting participants, sponsored by Cleveland Dental Institute.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

Observational study at CDI Cleveland Dental Institute. Investigators will assess the pain perception in one group of patients using two non-invasive methods. First, a numerical rate scale (NRS) and second, a brain wave EEG.

Interventions

  • DEVICE EEG EMOTIV

Study Locations (1)

Ohio

  • Cleveland Dental Institute - Cleveland

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2024-01-01
Est. Completion 2025-04
Cleveland Dental Institute

6 total trials

What NCT06510244 shows while recruiting

NCT06510244 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (67% lower).

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which EEG EMOTIV is the first listed.

NCT06510244 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06510244 about?

NCT06510244 is a clinical study titled "Pain Perception Measurement by EEG and NRS". Observational study at CDI Cleveland Dental Institute. Investigators will assess the pain perception in one group of patients using two non-invasive methods. First, a numerical rate scale (NRS) and second, a brain wave EEG.

What is the current status of trial NCT06510244?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-01-01. Estimated completion is 2025-04.

What conditions does trial NCT06510244 study?

This clinical trial studies the following conditions: Pain, Electroencephalography, Toothache.

What interventions are being tested in trial NCT06510244?

The interventions under investigation include: EEG EMOTIV (DEVICE).

Who is sponsoring clinical trial NCT06510244?

This trial is sponsored by Cleveland Dental Institute, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06510244 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06510244's enrollment target sits among peer trials

100 164th of 374 higher than 201 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06510244, the US trial registry maintained by the National Library of Medicine. NCT06510244 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.